• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

ResMed's Strong Charts Tell Bullish Story in Down Market

The maker of ventilators and CPAP machines saw shares sell off in March but its technical signs still look good.
By BRUCE KAMICH
Apr 02, 2020 | 08:19 AM EDT
Stocks quotes in this article: RMD

In an Executive Decision segment of "Mad Money" on Wednesday, host Jim Cramer spoke with Mick Farrell, CEO of ResMed Inc. (RMD) , a maker of ventilators and CPAP equipment.

Farrell said ResMed has been following the coronavirus pandemic from the beginning. All of its factories around the world are working around the clock, and their goal is to ship two to three times the number of ventilators they did last year and 10 times the number of masks.

Farrell said the bottleneck is not in manufacturing these units, but in procuring the 500 parts needed to build them. ResMed is looking to work with anyone who can help solve the parts problem, he said.

Let's take a look at the charts and indicators for any technical bottlenecks.

In this daily bar chart of RMD, below, we can see that prices sold off sharply from the middle of February to the middle of March -- a path all too familiar with millions of investors. Prices rebounded in recent sessions to regain the stock's position above the rising 200-day moving average line but still below the declining 50-day moving average line. Trading volume has been pretty good the past 12 months and surged to a high into the March nadir. This heavy volume may have been a washout of weaker holders.

The daily On-Balance-Volume (OBV) line shows a bullish rise right up into the middle of February and only a very modest decline since. This is a good sign that most holders of RMD stayed with their positions. It looks like the OBV line is attempting to turn higher again. The Moving Average Convergence Divergence (MACD) oscillator has crossed to the upside, generating a cover shorts buy signal.

In this weekly bar chart of RMD, below, we can see that the price of RMD has more than doubled in the past three years. Prices found support in the upper part of the big consolidation pattern in 2018 and early 2019. This decline was not a game changer for the stock. The 40-week moving average line is still pointed upward. The weekly OBV line only shows a recent minor dip and not weeks or months of aggressive selling. The MACD oscillator is still above the zero line and starting to narrow.

In this Point and Figure chart of RMD, below, we used daily price data to construct the chart. Here we can see that the software is projecting a potential upside price target of $194.

Bottom line strategy: Not only is ResMed in a business that is still operating and in high demand right now, but all the charts above also tell us a bullish story. They show a long multiyear rally with a correction down to a support zone. The Point and Figure chart shows a price target that is a new high. All we need to do is to go long around current levels and risk a close below $130 for now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Mad Money | Executive Interview | Real Money | Coronavirus

More from Stocks

Big Lots: Big Drop and Bearish

Bruce Kamich
May 27, 2022 12:15 PM EDT

The shares are sharply lower after its latest quarterly results.

This DXC Technology Rally Has Staying Power

Bruce Kamich
May 27, 2022 11:38 AM EDT

Here's our trading strategy.

Retailer Results Offer Clues as to the State of the Consumers They Serve

Bret Jensen
May 27, 2022 11:30 AM EDT

Some retailers are faring well while other are not, and it has a something to do with the income levels of their customers.

Urban Outfitters Is Showing No Signs of Renewal

Bruce Kamich
May 27, 2022 10:55 AM EDT

Shares of the retailer are likely to work still lower in the months ahead.

Look in the Basement for Bargains, If You Dare

Jonathan Heller
May 27, 2022 10:30 AM EDT

The ranks of companies trading below NCAV has been somewhat barren for a while, but you never know what you'll discover 'down there.'

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "The Tremendous Power of the Sell Button"
  • 02:46 PM EDT STEPHEN GUILFOYLE

    We're Shedding Some of This Holding on Strength

    Check out the Stocks Under $10 portfolio here!
  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login